Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation

Transplantation
Wolfgang GrotzKarlheinz Peter

Abstract

Aspirin treatment has an undoubted beneficial impact on the progression of cardiovascular diseases. We hypothesized that aspirin also protects allograft function and survival in the context of chronic renal allograft dysfunction, which displays decisive pathophysiologic features that are similar to those involved in atherogenesis. A retrospective, multivariate analysis was performed to assess the effect of low-dose aspirin treatment (100 mg/day) on allograft function and survival of 830 renal transplant recipients. Allograft function was evaluated by serum creatinine levels, urine protein levels, and the presence of hematuria. Median allograft survival time was significantly longer in patients receiving low-dose aspirin therapy compared with patients receiving no aspirin treatment (n=205, 13.8 +/- 2.6 vs. 7.8 +/- 0.3 years, n=625; adjusted relative risk=0.443, 95% confidence interval [0.323-0.608], P<0.0001). Statin treatment and a recent time point of transplantation, reflecting the qualitative advances of the applied immunosuppressive therapy, were further positive determinants of renal allograft survival. The number of antihypertensive agents, representing the extent of hypertension, was a negative determinant of allograft s...Continue Reading

References

Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Jan 14, 1999·The New England Journal of Medicine·R Ross
Apr 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·X M XuK K Wu
Aug 26, 1999·Nephron·R M Jindal, S Hariharan
Nov 27, 1999·Transplantation Proceedings·P HäyryH Savolainen
May 5, 2001·Immunity·P Libby, J S Pober
Dec 12, 2001·Circulation Research·U Schönbeck, P Libby
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
May 10, 2002·The New England Journal of Medicine·Michael S Lauer
Sep 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Galina K SukhovaPeter Libby
Oct 9, 2002·The Journal of Experimental Medicine·Steffen MassbergMeinrad Gawaz
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
Mar 21, 2003·The New England Journal of Medicine·Christopher HeeschenUNKNOWN CAPTURE Study Investigators

❮ Previous
Next ❯

Citations

Dec 1, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Aqeel JaveedYong Zhao
Jan 25, 2005·Transplantation·H HacksteinA W Thomson
Apr 25, 2007·Transplantation·Mario Abbud-FilhoFrancis L Delmonico
Dec 25, 2010·Transplantation·Pauline A Swift, Peter A Andrews
Jan 10, 2006·Seminars in Dialysis·Elizabeth A Kendrick, Connie L Davis
Jul 14, 2012·Human Immunology·Hsiao-Hsuan KuoWilliam M Baldwin
Dec 17, 2011·International Immunopharmacology·Muzammal HussainMuti Ur Rehman
Jul 10, 2007·Seminars in Nephrology·Phuong-Thu T PhamGabriel M Danovitch
Jul 24, 2007·Thrombosis Research·Baojun ZhangYong Zhao
Mar 29, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Patricia L Adams
Oct 23, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Jul 28, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M BucklandG Lombardi
Dec 11, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A D KirkW M Baldwin
Oct 17, 2006·Basic & Clinical Pharmacology & Toxicology·Gareth Morgan
Nov 10, 2010·Transplant International : Official Journal of the European Society for Organ Transplantation·Lutz Liefeldt, Klemens Budde
May 3, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Mads HornumBo Feldt-Rasmussen
Jun 18, 2010·Clinical Transplantation·Kyle L DawsonA Osama Gaber
Sep 19, 2006·International Immunopharmacology·Ratiya KukhetpitakwongWatcharee Khunkitti
Jan 7, 2017·Journal of Dental Research·Y LiuY H Zhou
Dec 19, 2015·Therapeutic Advances in Cardiovascular Disease·Francesco SummariaRoberto Patrizi
Feb 22, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Anushree C Shirali, Margaret J Bia
Nov 20, 2019·Current Opinion in Nephrology and Hypertension·Ekamol TantisattamoKamyar Kalantar-Zadeh
Oct 5, 2017·Journal of Nephropathology·Wisit CheungpasitpornStephen B Erickson
Aug 9, 2018·Clinical Kidney Journal·Claire KennedyDermot Kenny
Jun 22, 2019·Advances in Preventive Medicine·Muhammad Abdul Mabood KhalilJackson Tan
Dec 15, 2020·Transplantation·Benjamin P JonesJ Richard Smith
Feb 3, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Claudio PonticelliGiuseppe Montagnino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.